The Lancet, Early Online Publication, 6 January 2011
Reinhold Vieth a bIn The Lancet , Adrian Martineau and colleagues 1 report a randomised multicentre trial of vitamin D 3 (colecalciferol) as adjunctive therapy for active tuberculosis, 1 This study, and five other ongoing trials, 2—7 were all designed to show faster recovery from active infection with Mycobacterium tuberculosis .
Martineau and colleagues showed that the addition of vitamin D 3 shortened the time to sputum clearance by 1 week, from 43·5 to 36·0 days, but the decrease did not reach conventional statistical signi ...
Weblink here
